Trending News Today: High-Deductible Insurance Linked to Delays in Cancer Diagnosis, Care

Having high-deductible insurance plans may be linked to delays in cancer diagnosis and care, NPR reported. According to the article, a study published in Health Affairs examined claims data from a large national insurer for 316,244 women whose employers switched coverage from low-deductible health plans to high-deductible plans. Overall, women with low incomes who had high-deductible plans waited an average of 1.6 months longer for diagnostic breast imaging, 2.7 months for first biopsy, 6.6 months for first early-stage breast cancer diagnosis, and 8.7 months for first chemotherapy, compared with low-income women with low-deductible plans, the article reported. The study also showed that women with high incomes and high-deductible plans experienced delays as well.
 
A new study indicates that scientists have used HIV in gene therapy to treat patients with severe combined immunodeficiency syndrome, also called “bubble boy disease,” The Associated Press reported. According to the article, the therapy involves removing some of a patient’s blood cells, using the modified HIV to insert the missing gene, and returning the cells intravenously. Six to 24 months after treatment, all 8 infants treated are making all the cell types needed to fight infections, the article reported.
 
Very few smartphone apps that are designed to help patients with type 2 diabetes offer real-time guidance on how to handle dangerously high or low blood sugar, Reuters reported. According to the article, a study examined 5185 apps for phones running Google’s Android software or Apple’s iOS system. Of the apps examined, the researchers found 371 that claimed to provide several diabetes management features, such as recording blood sugar data, reminding patients when they need to do specific things to manage the illness, and educating patients on what to do for conditions such as dangerously low or high blood sugar.
 



Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 


Related Articles

A specialty pharmacy’s specific expertise and experience in supporting patients with cancer is among its most essential attributes.
A novel potential biomarker test could identify patients who would benefit from more advanced lung cancer screening.
Top news of the day from across the health care landscape.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2019
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$